PulManage’s platform advances care for chronic lung diseases by remotely connecting patients with healthcare providers to confirm diagnoses and enhance care management. The product includes patient-facing mobile apps that monitor and record lung function and provide real-time feedback via an online dashboard for researchers and clinicians. The company’s stated mission is to improve management of conditions such as COPD, cystic fibrosis, asthma, and other chronic lung diseases and to reduce misdiagnosis. PulManage has matured through the SC Launch Program and has received multiple grants and investment support from the South Carolina Research Authority. It has been invited by Amazon Web Services Life Sciences to represent its product at the AWS Life Sciences Annual Summit and will attend the International BIO convention as part of the South Carolina delegation. The company is based in Columbia, South Carolina.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

May 2024